NEW GOODRX REPORT UNDERSCORES NEED FOR CONGRESS TO HOLD BIG PHARMA ACCOUNTABLE

Latest Data Finds List Prices of Prescription Drug Prices Have Increased Nearly 40 Percent Since 2016

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday reacting to a new report from GoodRx examining the rising price of prescription drugs.

“The new report from GoodRx exposes Big Pharma for hiking prescription drug prices on the American people by 40 percent since 2016, costing patients $21 billion,” said CSRxP executive director Lauren Aronson. “To deliver relief for patients from Big Pharma’s price-gouging and patent abuse, policymakers must crack down on Big Pharma’s price hikes on existing products, increasingly out-of-control launch prices on new products and egregious anti-competitive tactics.”

The GoodRx report found that since 2016, the list price of all prescription drugs has increased nearly 40 percent and that $21 billion has been spent out-of-pocket on prescription drugs so far this year. Read the full report HERE.

Read more about CSRxP HERE.

Read more about bipartisan, market-based solutions to hold Big Pharma accountable and lower prescription drug prices HERE.